Celanese (CE) Company Report

On December 17, 2025, Celanese US Holdings LLC completed a registered offering of $1.4 billion of senior notes ( $600 million 7.000% due 2031; $800 million 7.375% due 2034).
Net proceeds and cash were used to repurchase $946 million of 6.665% notes due 2027, $254 million of 6.850% notes due 2028, repay $130 million under its five-year term loan due 2027, and cover related fees.
The transactions extend Celanese’s average debt maturity from 4.1 to 4.7 years, reduce 2026–2028 maturities from $4.7 billion to $3.4 billion, and set an effective net borrowing rate of 5.31 % (up 2 bps).
CFO Chuck Kyrish highlighted the move aligns maturities with free cash flow outlook, supports EBITDA growth and targets a net debt to Operating EBITDA ratio of 3×.

1 day ago

Press Release

Celanese completes $1.4 billion senior notes offering

Debt Issuance

On December 17, 2025, Celanese US Holdings LLC issued $600 million of 7.000% Senior Notes due 2031 and $800 million of 7.375% Senior Notes due 2034 under its May 6, 2011 Indenture.
Net proceeds, together with available cash, will repay the outstanding five-year term loan due 2027, fund upsized tender offers for approximately $1.2 billion aggregate principal amount of Senior Notes due 2027 and 2028, and support general corporate purposes.
The Notes are guaranteed on a senior unsecured basis by Celanese Corporation and certain subsidiaries, and pay interest semi-annually on February 15 and August 15 beginning August 15, 2026.

1 day ago

8-K

Celanese upsizes tender offers for 2027 and 2028 senior notes

Debt Issuance

On December 16, 2025, Celanese US Holdings LLC announced early results and increased the Maximum Tender Amount to $1,200,106,000 for its 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028, and set the Series Cap at $254,000,000 for the 2028 Notes.
As of the Early Tender Time, $946,106,000 of the 2027 Notes and $675,185,000 of the 2028 Notes had been validly tendered; the company expects to accept $946,106,000 of the 2027 Notes and $254,000,000 of the 2028 Notes (proration factor of 37.68%).
Total consideration per $1,000 principal amount is $1,037.50 for the 2027 Notes and $1,055.00 for the 2028 Notes, inclusive of a $50 Early Tender Payment.
Settlement of accepted notes is expected on December 17, 2025, and the tender offers’ financing condition has been satisfied.

3 days ago

8-K

Celanese announces early results and upsizing of tender offers

Celanese US Holdings LLC received valid tenders of $946.106 million of 6.665% Senior Notes due 2027 and $675.185 million of 6.850% Senior Notes due 2028, and expects to accept $946.106 million of the 2027 Notes and $254 million of the 2028 Notes (37.68% proration for the 2028 series).
The tender offers were upsized to a $1,200.106 million maximum tender amount and a $254 million series cap for the 2028 Notes.
Holders validly tendering at or before the early deadline will receive $1,037.50 per $1,000 of 2027 Notes and $1,055.00 per $1,000 of 2028 Notes (including a $50 early tender payment), with settlement expected on December 17, 2025.

3 days ago

Press Release

Celanese Corp issues $1.4 B senior notes

Debt Issuance

Celanese US Holdings LLC, a subsidiary of Celanese Corporation, agreed to offer $600 million of 7.000% Senior Notes due 2031 and $800 million of 7.375% Senior Notes due 2034 in an underwritten public offering led by BofA Securities.
Net proceeds will be used to repay outstanding borrowings under its Five-Year Term Loan, fund tender offers for its 6.665% notes due 2027 and 6.850% notes due 2028, and for general corporate purposes, including repayment of other indebtedness.
The notes are priced at 99.00% of principal plus accrued interest from December 17, 2025, with closing and settlement expected on December 17, 2025.
The securities will be fully and unconditionally guaranteed by Celanese Corporation and designated subsidiaries, and issued under the Base Indenture dated May 6, 2011, as supplemented.

Dec 4, 2025, 9:30 PM

8-K

Celanese launches tender offers for 2027 and 2028 senior notes

On December 2, 2025, Celanese’s wholly-owned subsidiary commenced cash tender offers to repurchase up to $1.0 billion of its 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028, with a $100 million cap on the 2028 series.
Notes validly tendered by the Early Tender Time (5:00 p.m. ET on December 15, 2025) will receive Total Consideration of $1,037.50 per $1,000 of 2027 notes and $1,055.00 per $1,000 of 2028 notes (including a $50 early tender payment); tenders after this but before the Expiration Time (5:00 p.m. ET on December 31, 2025) receive the consideration minus the early payment.
Repurchased notes will be retired and cancelled at settlement, which is subject to a Financing Condition requiring a concurrent debt offering to fund the repurchases.

Dec 2, 2025, 12:26 PM

8-K

Celanese reports Q3 2025 earnings and 2026 outlook

Earnings

Guidance Update

M&A

Celanese delivered Q3 EPS of $1.34, reflecting ongoing execution on cash flow, cost improvements, and top-line growth priorities.
Management expects to grow EPS by $1–$2 in 2026 through cost actions and engineered materials pipeline progress, even if demand remains flat.
Announced closure of the Narco acetate tow facility in Europe, targeting $20M–$30M of productivity savings in 2027.
Completed sale of Micromax for $500M gross proceeds, with 5% tax leakage, achieving half of the $1B divestiture goal by end-2027.
Generated $250M of working capital cash source in 2025, expects neutral working capital in Q4, and projects sustainable free cash flow of $700M–$800M in 2026.

Nov 7, 2025, 2:00 PM

Transcript

Celanese reports Q3 2025 results and 2026 outlook

Earnings

Guidance Update

M&A

Celanese delivered $1.34 EPS in Q3 2025, with engineered materials volumes down 8% year-over-year as standard-grade products declined while thermoplastic elastomers held up.
Management expects $1–$2 of EPS growth in 2026, split roughly equally between cost actions and engineered materials pipeline gains, assuming flattish demand.
Completed the $500 M Micromax divestiture, realizing proceeds net of ~5% tax and reaching half of the $1 B divestiture target by 2027.
Announced closure of the Lanaken acetate tow facility, targeting $20–$30 M of annual productivity savings by 2027 and optimizing low-cost assets across the network.
Generated $250 M of working capital cash in 2025, expect zero net working capital change in Q4, and project $700–$800 M of free cash flow in 2026 at the low end as sustainable.

Nov 7, 2025, 2:00 PM

Transcript

Celanese reports Q3 2025 results

Earnings

Guidance Update

Celanese generated $375 million in free cash flow and delivered $1.34 adjusted EPS for Q3 2025.
Segment adjusted EBIT was $200 million for Engineered Materials and $187 million for Acetyl Chain, with EM benefiting from improved mix and AC margins remaining above 20% despite an unplanned outage.
Company remains on track to achieve its FY2025 free cash flow target of $700–$800 million, ending Q3 with $1.4 billion in cash and a $1.75 billion undrawn revolving credit facility.
Q4 2025 adjusted EPS is guided at $0.85–$1.00, with segment EBIT guidance of $165–$175 million for EM and $165–$180 million for AC.

Nov 7, 2025, 2:00 PM

Presentation

Celanese forecasts $1–$2 EPS growth for fiscal 2026

Guidance Update

M&A

Demand Weakening

Celanese expects to grow EPS by $1–$2 in 2026, driven roughly half by ongoing cost actions and half by engineered materials pipeline gains, even in a flattish demand environment.
Engineered materials volumes were down 8% year-over-year in Q3, driven by standard-grade thermoplastics (POM, nylon, GUR, polyesters), while thermoplastic elastomers held up; EM pricing improved, marking the strongest quarter in eight periods.
In the acetyl chain, lowest-cost assets (U.S.) operated at 100% utilization, with other global units flexed to match demand; block operation of Singapore and Frankfurt sites will continue into 2026.
Completed the $500 million Micromax divestiture, advancing toward the $1 billion divestiture target by 2027; net proceeds face a 5% tax leakage.
Generated a $250 million working capital cash source in 2025, with Q4 WC neutral; free cash flow is anticipated at least $700 million in 2026, reflecting lower restructuring and sustained cash conversion.

Nov 7, 2025, 2:00 PM

Transcript

Earnings Transcripts

Quarterly earnings call transcripts for Celanese.

Q3 2025

Nov 7, 2025

→

Q2 2025

Aug 12, 2025

→

Q1 2025

May 6, 2025

→

View All Transcripts

Ask Fintool AI Agent

Get instant answers from SEC filings, earnings calls & more

What did Scott Richardson say about margins?What are Celanese's strategic priorities?How is Celanese positioned vs competitors?How did Celanese do last quarter?

Celanese (CE)

Analyst Earnings Quarterly Reports

Q3 2025

Q2 2025

Q1 2025

Q4 2024

Executives

Scott Richardson

Ashley Duffie

Chuck Kyrish

Mark Murray

Todd Elliott

Board Members

Bruce Chinn

Christopher Kuehn

David Hoffmeister

Deborah Kissire

Edward Galante

Ganesh Moorthy

Jay Ihlenfeld

Kathryn Hill

Kim Rucker

Michael Koenig

Scott Sutton

Timothy Go

Analyst Coverage

Aleksey Yefremov

Arun Viswanathan

Ghansham Panjabi

Hassan Ahmed

Jeffrey Zekauskas

John Ezekiel Roberts

Patrick Cunningham

Salvator Tiano

Vincent Andrews

David Begleiter

Frank Mitsch

Michael Sison

Joshua Spector

Kevin McCarthy

Matthew Blair

Josh Spector

Laurence Alexander

Mike Sison

Aziza Gazieva

James Cannon

John McNulty

Michael Leithead

Latest news

Earnings Transcripts

Q3 2025

Q2 2025

Q1 2025

Ask Fintool AI Agent